Basket | Login | Register


SS3. Clinical trials education

Detailed programme, abstracts and presentations

SS3. The evolving role of patients advocacy groups in clinical trials education

Scheltens Philip, Geipel Gary

This interactive symposium will explore the evolving role of patients advocacy groups in clinical trials education. Gary Geipel, Senior Director for Oncology Corporate Affairs at Eli Lilly & Co will present the key findings of a large, six-country (United States, France, Germany, Italy, Japan and the United Kingdom) survey of the general public, as well as cancer patients and caregivers to determine attitudes and beliefs to cancer innovation and treatment. Known as the PACE Cancer Perceptions Index, this survey provides insights on how the public and cancer patients perceive clinical trials and the potential risks and benefits of taking part in them. Professor Philip Scheltens, Director of the Alzheimer Centre at the Vrije Universiteit Medical Centre in Amsterdam will lead the interactive discussions to identify the lessons that can be learned from the cancer field to improve and increase the role of patient advocacy groups in clinical trials in the field of Alzheimer’s disease.This special symposium is organised by Eli Lilly & Co.



Last Updated: Monday 25 November 2013


  • Acknowledgements

    The 23rd Alzheimer Europe Conference in St. Julian's, Malta received funding from the European Union, in the framework of the Health Programme. Alzheimer Europe and the Malta Dementia Society gratefully acknowledge the additional support provided by foundations and companies.
  • European Union